1. Introduction {#sec1}
===============

The skin is the organ that covers all of the body and is mainly composed of the epidermis and dermis. The epidermis consists of keratinocytes (approximately 90%) and melanocytes (5--10%) [@bib1]. Melanocytes originate from neural crest cells and synthesize melanin pigments [@bib2]. Skin pigmentation plays many beneficial roles that include determination of skin color of humans and ultraviolet (UV) radiation protection [@bib3]. Excessive exposure to UV-B (280--320nm) accelerates skin aging such as wrinkle formation and hyperpigmentation [@bib1]. Production of proinflammatory cytokines and growth factors mediates skin damage [@bib4]. There is evidence showing that granulocyte--macrophage colony-stimulating factor (GM-CSF) is an important cytokine in the control of the proliferation and differentiation of melanocytes in pigmented spots induced by UV [@bib5]. Previous studies have shown that protein kinase C (PKC) and the following activation of the extracellular signal--regulated kinase (ERK) pathway regulate GM-CSF expression [@bib6].

PKC is composed of a large family of 11 members of kinases, which are categorized into conventional (cPKCs; α, βI, βII, γ), novel (nPKCs; δ, e, η, θ, μ), and atypical (aPKCs; τ, ζ) protein kinases [@bib7], [@bib8]. The cPKCs and nPKCs can be stimulated using phorbol esters and diacylglycerol; on the other hand, the aPKCs have been reported to show no response to phorbol esters and diacylglycerol either *in vivo* or *in vitro* [@bib9]. It has been reported that UV-B markedly induces the activation of PKCδ and PKCε but has no effect on PKCα [@bib10], [@bib11]. The Korean Red Ginseng (KRG) saponin has been known to exert anticancer, antiaging, antioxidant, and antiinflammatory effects, with a low rate of adverse effects [@bib12], [@bib13].

Previous studies have shown that UV-B irradiation stimulated production of GM-CSF in SP-1 keratinocytes and that this induction of GM-CSF promoted mouse melanocyte proliferation. In addition, KRG saponin inhibited secretion of GM-CSF from mouse keratinocytes induced by UV-B [@bib12].

Saponin consists of various ginsenosides that are divided into two major groups, the panaxadiols and panaxatriols, based on the chemical structure [@bib13]. Ginsenosides are the main compounds responsible for most of the pharmacological and immunological effects of saponin [@bib14]. However, the inhibitory mechanisms of ginsenoside activity on UV-induced skin pigmentation still remain unclear. In this research, we investigated the inhibitory mechanism of ginsenoside Rh3 in cellular protection against expression and release of GM-CSF induced by UV-B in SP-1 keratinocytes.

2. Materials and methods {#sec2}
========================

2.1. Cell line and cell culture {#sec2.1}
-------------------------------

SP-1 keratinocytes from Sencar mice were kindly gifted from Dr. Stuart H. Yuspa (Laboratory of Cellular Carcinogenesis and Tumor Promotion, National Cancer Institute, NIH, USA). Eagle's minimum essential medium (EMEM) complemented with 8% Chelex-treated heat-inactivated newborn calf serum (Carlsbad, CA, USA), 1% penicillin--streptomycin, and 0.05 mM Ca^2+^ was used for the *in vitro* culture of the SP-1 keratinocytes.

2.2. Materials {#sec2.2}
--------------

Ginsenosides compound K, F1, F2, Rb1, Rb2, Rb3, Rc, Rd, Re, Rh1, Rh3, Rg1, Rg2, Rf, and Ro were provided by Korea Ginseng Corporation (Daejeon, Korea).

2.3. Irradiation {#sec2.3}
----------------

For irradiation, the medium was changed to Dulbecco\'s phosphate-buffered saline, and the keratinocytes were treated with UV-B (30 mJ/cm^2^). The cells were then maintained in EMEM containing 2% newborn calf serum for the indicated times.

2.4. Cell viability assay {#sec2.4}
-------------------------

The SP-1 keratinocytes were cultured and placed in 96-well plates (1.0 × 10^4^ cells/well). After 24 h, the cells were treated with ginsenoside Rh3 (1, 10, 100, and 1000 μM) and incubated for 24 h. Then, cell viabilities were determined using an EZ-Cytox assay kit (Daeil Lab Service, Seoul, Korea).

2.5. Reverse transcription polymerase chain reaction analysis {#sec2.5}
-------------------------------------------------------------

TRIzol reagent (Takara Bio, Inc., Tokyo, Japan) was used to extract total RNAs from the SP-1 keratinocytes. Complementary DNAs were amplified by reverse transcription polymerase chain reaction (RT-PCR) using the following primers: GM-CSF, forward: 5′ - GCCATC AAAGAAGCCCTGAA - 3′ and reverse: 5′ - GCGGGTCTGCACACATGT TA - 3′. The mouse β-actin gene served as the normalization control. PCR amplifications were performed for 28 cycles under the optimal condition of denaturation at 95°C, annealing at 59°C, and extension at 70°C. The product of PCR amplification was separated on 2% agarose gels and detected by using RedSafe Nucleic Acid Staining Solution (iNtRON Biotechnology, Seongnam, Korea).

2.6. Western blot analysis {#sec2.6}
--------------------------

Total extracts were prepared with radioimmunoprecipitation assay buffer (RIPA buffer) (Noble Bio, Hwaseong, Korea) containing 1 mM phenylmethanesulfonyl fluoride and protease inhibitor cocktail (cat\#P8340; Sigma, St. Louis, MO, USA). The proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) using NuPAGE 10% Bis--Tris gels and transferred to a polyvinylidene fluoride transfer membrane (Pall Corporation, Port Washington, NY, USA) using NuPAGE 3-(N-morpholino) propane sulphonic acid (MOPS) SDS running buffer (cat\# NP0001; Invitrogen) and NuPAGE transfer buffer 20× (cat\# NP0006; Invitrogen™).

Western blot was performed using antibodies against anti--GM-CSF antibody (Abcam, Cambridge, UK), anti--phospho-p42/44 mitogen-activated protein kinase (MAPK) (ERK1/2) antibody, anti--p42/44 MAPK (ERK1/2) antibody (Cell Signaling Technology, Beverly, MA, USA), anti--PKCα antibody (Santa Cruz Biotechnology, Dallas, TX, USA), anti--PKCδ antibody (Santa Cruz Biotechnology, Dallas, TX, USA), anti--phospho-PKCα antibody (Abcam, Cambridge, MA), anti--phospho-PKCδ antibody (Abcam, Cambridge, MA), anti--β-actin antibody (Sigma, St. Louis, MO, USA), goat anti--mouse IgG antibody (Bio-Rad Laboratories Inc, Hercules, CA, USA), and rabbit IgG heavy- and light-chain antibody (Bethyl Laboratories, Montgomery, Texas, USA). The membranes were incubated in WEST-ZOL plus (iNtRON Biotechnology, Seongnam, Korea), and ChemiDoc XRS densitometry systems (Bio-Rad) were used for visualization.

2.7. Measurement of GM-CSF by enzyme-linked immunosorbent assay {#sec2.7}
---------------------------------------------------------------

Culture supernatants were collected 24 h after UV-B irradiation. The medium was centrifuged at 1000 rpm for 5 min and stored at −80°C. The GM-CSF in the culture supernatants was determined using a mouse GM-CSF enzyme-linked immunosorbent assay kit (eBioscience, San Diego, CA, USA) as per the manufacturer\'s instructions.

2.8. Statistical analysis {#sec2.8}
-------------------------

All values are expressed as mean ± standard error of mean. Significant differences between the results were evaluated using the Student *t* test. The *p*-values \< 0.05 were regarded as statistically significant.

3. Results {#sec3}
==========

3.1. Ginsenoside Rh3 inhibited production of GM-CSF in the UV-B--exposed SP-1 keratinocytes {#sec3.1}
-------------------------------------------------------------------------------------------

We identified 15 types of ginsenosides to determine which ginsenoside reduced GM-CSF expression in SP-1 keratinocytes. Enzyme-linked immunosorbent assaywas used to quantify the GM-CSF levels from the SP-1 keratinocyte--cultured media. GM-CSF was increased in the culture media after UV-B exposure compared with the nonirradiated control cell media. Among the compounds tested, ginsenoside Rh3 resulted in an approximate 40% decrease in the GM-CSF level. Based on these results, we selected ginsenoside Rh3 for further study ([Fig. 1](#fig1){ref-type="fig"}).Fig. 1Ginsenoside Rh3 inhibited production of GM-CSF in the UV-B--exposed SP-1 keratinocytes. SP-1 cells were treated with 15 types of ginsenosides: (1) ginsenoside compound K, (2) ginsenoside F1, (3) ginsenoside F2, (4) ginsenoside Rb1, (5) ginsenoside Rb2, (6) ginsenoside Rb3, (7) ginsenoside Rc, (8) ginsenoside Rd, (9) ginsenoside Re, (10) ginsenoside Rh1, (11) ginsenoside Rh3, (12) ginsenoside Rg1, (13) ginsenoside Rg2, (14) ginsenoside Rf, and (15) ginsenoside Ro (10 μM). After 24 h, the cells were exposed to UV-B (30 mJ/cm^2^) and were treated with 15 types of ginsenosides. GM-CSF levels in the supernatant were measured by ELISA. \*\*\**p* \< 0.001, compared with the UV-B--treated control group. \#\#*p* \< 0.01 compared with dimethyl sulfoxide (D) 0.1% control. \*\*\**p* \< 0.001 compared with the UV-B control, n = 3.ELISA, enzyme-linked immunosorbent assay; GM-CSF, granulocyte--macrophage colony-stimulating factor.Fig. 1

3.2. Effect of ginsenoside Rh3 on cell viability {#sec3.2}
------------------------------------------------

The cytotoxic effect of ginsenoside Rh3 was investigated on the SP-1 keratinocytes. We found that ginsenoside Rh3 did not affect cell viability at concentrations of 1--1000 μM ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2SP-1 keratinocyte viability assay. Cell viability of the SP-1 keratinocytes under treatment with ginsenoside Rh3 (1, 10, 100, and 1000 μM) was determined by EZ-Cytox assay. These experiments were performed in triplicate.DMSO, dimethyl sulfoxide.Fig. 2

3.3. Ginsenoside Rh3 reduced 12-O-tetradecanoylphorbol-13-acetate--induced GM-CSF production {#sec3.3}
--------------------------------------------------------------------------------------------

We investigated whether ginsenoside Rh3 could inhibit 12-O-tetradecanoylphorbol-13-acetate (TPA)--induced GM-CSF production in SP-1 cells. H7 (PKC inhibitor) was used as a positive control for the reduction in GM-CSF induced by TPA. We found that ginsenoside Rh3 reduced production of GM-CSF induced by 50 nM TPA in a dose-dependent manner ([Fig. 3](#fig3){ref-type="fig"}).Fig. 3Ginsenoside Rh3 reduced TPA-induced GM-CSF production. SP-1 cells were treated with 50 nM TPA after 24 h of treatment with ginsenoside Rh3. Six hours later, the conditioned medium was collected to measure the concentration of GM-CSF. Expression of GM-CSF was detected by ELISA. ^\#\#\#^*p* \< 0.001 compared with dimethyl sulfoxide (D, "DMSO") 0.1% control, \**p* \< 0.05, \*\**p* \< 0.01 compared with the TPA-treated group, n = 3.ELISA, enzyme-linked immunosorbent assay; GM-CSF, granulocyte--macrophage colony-stimulating factor; TPA, 12-O-tetradecanoylphorbol-13-acetate.Fig. 3

3.4. Ginsenoside Rh3 reduced TPA-induced GM-CSF mRNA expression {#sec3.4}
---------------------------------------------------------------

The SP-1 cells were treated with 50 nM TPA and ginsenoside Rh3 for 0, 3, and 6 h. To detect the GM-CSF mRNA level, we used RT-PCR. We observed that GM-CSF mRNA levels significantly increased at 3 and 6 h after TPA treatment and that ginsenoside Rh3 and H7 decreased the GM-CSF mRNA level in the TPA-treated SP-1 cells at 6 h ([Fig. 4](#fig4){ref-type="fig"}).Fig. 4Ginsenoside Rh3 reduced TPA-induced GM-CSF mRNA expression. The SP-1 keratinocytes were treated with ginsenoside Rh3 (4 μM and 8 μM). After 24 h, the cells were treated with 50 nM TPA. After UV-B irradiation, the cells were treated with 2% NBCS EMEM containing ginsenoside Rh3. (A) After 3 h and 6 h, the RNA level of GM-CSF was detected by RT-PCR. (B) The RNA level of GM-CSF was quantified using Image J software. The level of β-actin was used for loading control. ^\#^*p* \< 0.05 compared with DMSO (D) 0.1% control, ^∗^*p* \< 0.05 compared with the TPA control, n = 3.DMSO, dimethyl sulfoxide; EMEM, Eagle's minimum essential medium; GM-CSF, granulocyte--macrophage colony-stimulating factor; NBCS, newborn calf serum; RT-PCR, reverse transcription polymerase chain reaction; TPA, 12-O-tetradecanoylphorbol-13-acetate.Fig. 4

3.5. Differential activity of PKC isoforms in the UV-B radiation--induced SP-1 keratinocytes {#sec3.5}
--------------------------------------------------------------------------------------------

We then examined which PKC isoforms are activated by UV-B radiation. By Western blot analysis, we confirmed that the PKCδ isoform was activated 5 min after UV-B exposure. However, the PKCα isoform was not activated after UV-B irradiation ([Fig. 5](#fig5){ref-type="fig"}). These results demonstrated that PKCδ is involved in UV-B--induced GM-CSF expression.Fig. 5Differential activity of PKC isoforms in the UV-B radiation--induced SP-1 keratinocytes. SP-1 cells were exposed to UV-B (30 mJ/cm^2^) for different time points. The level of phospho-PKCδ (pPKCδ), total PKCδ (PKCδ), phospho-PKCα (pPKCα), and total PKCα (PKCα) was determined by Western blot at the indicated times.PKC, protein kinase C.Fig. 5

3.6. Effect of ginsenoside Rh3 on phosphorylation of PKCδ induced by TPA in the SP-1 keratinocytes {#sec3.6}
--------------------------------------------------------------------------------------------------

We identified whether ginsenoside Rh3 could suppress the TPA-induced phosphorylation of PKCδ and ERK. We observed that the phosphorylation levels of PKCδ and ERK increased rapidly after 3 min of 100 nM TPA treatment and that ginsenoside Rh3 reduced the phosphorylation ([Fig. 6](#fig6){ref-type="fig"}A). The results of the Western blot analysis of phospho-PKCδ and phospho-ERK were quantified using an image analyzer ([Fig. 6](#fig6){ref-type="fig"}B and C).Fig. 6Effect of ginsenoside Rh3 on phosphorylation of PKCδ and ERK induced by TPA in the SP-1 keratinocytes. The SP-1 keratinocytes were treated with ginsenoside Rh3 (4 and 8 μM). After 24 h, a mixture of ginsenoside Rh3 and 100 nM TPA was applied to the keratinocytes for 2 min. (A) The phosphorylated forms of PKCδ and ERK were analyzed by Western blot analysis. (B) The relative intensity of phospho-PKCδ and ERK was quantified using Image J software. Band densities of phospho-PKCδ were normalized to those of total PKCδ. Band densities of phospho-ERK were normalized to those of total ERK. ^\#\#\#^*p* \< 0.001 compared with DMSO (D) 0.1% control, \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001 compared with TPA control, n = 3.DMSO, dimethyl sulfoxide; ERK, extracellular signal--regulated kinase; PKC, protein kinase C; TPA, 12-O-tetradecanoylphorbol-13-acetate.Fig. 6

4. Discussion {#sec4}
=============

Exposure to continuous and excessive UV-B radiation is a major cause of skin damage including sunburn, skin aging, erythema, and skin cancer [@bib15]. UV irradiation promotes the secretion of various inflammatory cytokines and chemokines from keratinocytes [@bib4], [@bib16]. It is known that GM-CSF is produced by UV irradiation in keratinocytes and increases skin pigmentation by controlling the proliferation and differentiation of melanocytes [@bib17]. In our previous study, treatment with KRG saponin and ginsenoside Rh3 decreased GM-CSF release and expression in UV radiation--exposed keratinocytes [@bib18]. Saponin consists of various ginsenosides, which have numerous functions [@bib12]. We tested 15 types of ginsenosides to identify which ginsenosides repress GM-CSF expression. We found that ginsenoside Rh3 inhibited GM-CSF production in UV-B--exposed SP-1 keratinocytes ([Fig. 1](#fig1){ref-type="fig"}). Ginsenoside Rh3 is a metabolite of ginsenoside Rg5 in humans [@bib19]. Pharmacological studies found that ginsenoside Rg5 and Rh3 have anticancer and antiinflammatory activities [@bib19], [@bib20]. In addition, Rh3 was reported to inhibit lipopolysaccharides (LPS-)induced cytokines such as inducible nitric oxide synthase, tumor necrosis factor-α, and interleukin-1β (IL-1β) [@bib21]. In our study, ginsenoside Rh3 suppressed TPA-induced GM-CSF protein expression ([Fig. 3](#fig3){ref-type="fig"}) and reduced GM-CSF mRNA level in the TPA-treated SP-1 cells ([Fig. 4](#fig4){ref-type="fig"}). The cPKC and nPKC can be directly activated by TPA and inhibited by H7 [@bib22], [@bib23]. It has been reported that PKC signaling is activated in response to UV irradiation [@bib24]. However, the PKC isoforms have different functions and reactions. UV irradiation activates phosphorylation of PKCδ, but not PKCα [@bib25]. We investigated whether phosphorylation of PKC isoforms is activated by UV-B irradiation in SP-1 cells. After UV-B irradiation (30 mJ/cm^2^ ), PKCδ was phosphorylated after 5 min, and this phosphorylation was maintained for 1 hr. However, PKCα was not phosphorylated by UV-B irradiation ([Fig. 5](#fig5){ref-type="fig"}). These results demonstrate that PKCδ is involved in UV-B--induced GM-CSF production. The PKC-ERK pathway regulates proliferation and differentiation and is an antiapoptotic pathway in keratinocytes [@bib26]. It has been reported that PKC activates MAPK/ERK Kinase (MEK)-ERK pathway [@bib27]. Furthermore, phosphorylation of ERK contributes to the generation of GM-CSF through the translation and stabilization of GM-CSF [@bib28]. Similar to UV-B irradiation, treatment of cells with TPA increased phosphorylation of ERK and PKCδ. We found that ginsenoside Rh3 inhibited TPA-induced phosphorylation of PKCδ and ERK ([Fig. 6](#fig6){ref-type="fig"}). Taken together, we identified that UV-B increased GM-CSF expression through PKCδ activation. Our results showed the inhibitory effect of ginsenoside Rh3 on UV-B--induced GM-CSF expression and the inhibitory mechanism of GM-CSF through the repression of PKCδ phosphorylation in SP-1 cells. Thus, our finding shows that ginsenoside Rh3 can suppress UV-B--induced PKCδ activation. GM-CSF is also induced by UV light and has autocrine or paracrine function in human skin [@bib29], [@bib30]. It is therefore possible that ginsenoside Rh3 has an effect on the production of GM-CSF in cultured human keratinocytes.

PKCδ has been known to implicate in various cellular processes such as apoptosis, migration, and differentiation [@bib9], [@bib31], [@bib32]. In addition, PKCδ plays an important role in regulation of inflammatory cytokines, including IL-6, IL-8, and interferon-γ. Immunohistochemistry and PCR analysis showed decreased expression of IL-6 and monocyte chemoattractant protein-1 in the aortic tissues of PKCδ knockout mice [@bib33], [@bib34]. Despite the fact that PKCδ is involved in diverse biological activities such as glucose metabolism, neuropathogenesis, and tonic tension, few PKCδ inhibitors have been reported [@bib35], [@bib36], [@bib37], [@bib38]. Recently, we found that ginsenoside Rh3 decreased the proliferation of mouse melanocytes through downregulation of microphthalmia-associated transcription factor, a key regulator of melanocytes [@bib39]. In this regard, we suggest that ginsenoside Rh3 may be a bioactive compound targeting PKCδ and a potential agent to suppress UV-B--induced skin pigmentation.

An earlier report has shown that ginsenoside Re has a protective role in methamphetamine-induced apoptosis via PKCδ inhibition in SH-SY5Y neuroblastoma cells [@bib40]. In contrast, other groups suggested that ginsenoside Rh2 induced PKCδ activity and apoptosis in SK-HEP-1 hepatoma cells [@bib41]. Our findings that ginsenoside Rh3 may be a potential PKCδ inhibitor can be applied to the aforementioned studies. Further studies on the effect of ginsenoside Rh3 on reactive oxygen species produced by UV-B, based on the reported result that the PKCs are regulated by UV-induced reactive oxygen species, will need to be performed [@bib42], [@bib43].
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